178 related articles for article (PubMed ID: 495427)
1. Value and limitations of technetium-99m stannous pyrophosphate in the detection of acute myocardial infarction.
Codini MA; Turner DA; Battle WE; Hassan P; Ali A; Messer JV
Am Heart J; 1979 Dec; 98(6):752-62. PubMed ID: 495427
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m stannous pyrophosphate myocardial scintiphotos in patients admitted to rule out acute myocardial infarction.
Okada RD; Woolfenden JM; Raessler KL; Groves BM; Marcus RI
Cardiology; 1977; 62(4-6):305-14. PubMed ID: 589613
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy.
Poliner LR; Buja LM; Parkey RW; Bonte FJ; Willerson JT
Circulation; 1979 Feb; 59(2):257-67. PubMed ID: 758994
[TBL] [Abstract][Full Text] [Related]
4. Validation of technetium-99m stannous pyrophosphate myocardial scintigraphy for diagnosing acute myocardial infarction more than 48 hours old when serum creatine kinase-MB has returned to normal.
Olson HG; Lyons KP; Butman S; Piters KM
Am J Cardiol; 1983 Aug; 52(3):245-51. PubMed ID: 6869268
[TBL] [Abstract][Full Text] [Related]
5. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
6. Limited clinical diagnostic specificity of technetium-99m stannous pyrophosphate myocardial imaging in acute myocardial infarction.
Ahmad M; Dubiel JP; Logan KW; Verdon TA; Martin RH
Am J Cardiol; 1977 Jan; 39(1):50-4. PubMed ID: 831427
[TBL] [Abstract][Full Text] [Related]
7. Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction.
Olson HG; Lyons KP; Aronow WS; Brown WT; Greenfield RS
Circulation; 1977 Aug; 56(2):181-7. PubMed ID: 872308
[TBL] [Abstract][Full Text] [Related]
8. Correlation of false negative myocardial infarct scintigraphy with postmortem studies.
Codini MA; Hawkins ET; Turner DA
Clin Cardiol; 1981 Jan; 4(1):47-50. PubMed ID: 6892492
[TBL] [Abstract][Full Text] [Related]
9. Technetium 99m stannous pyrophosphate myocardial imaging in patients with and without left ventricular aneurysm.
Ahmad M; Dubiel JP; Verdon TA; Martin RH
Circulation; 1976 May; 53(5):833-8. PubMed ID: 177228
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.
Willerson JT; Parkey RW; Bonte FJ; Lewis SE; Corbett J; Buja LM
Semin Nucl Med; 1980 Jan; 10(1):54-69. PubMed ID: 6246640
[TBL] [Abstract][Full Text] [Related]
11. The high-risk angina patient. Identification by clinical features, hospital course, electrocardiography and technetium-99m stannous pyrophosphate scintigraphy.
Olson HG; Lyons KP; Aronow WS; Stinson PJ; Kuperus J; Waters HJ
Circulation; 1981 Oct; 64(4):674-84. PubMed ID: 6456087
[TBL] [Abstract][Full Text] [Related]
12. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction.
Wheelan K; Wolfe C; Corbett J; Rude RE; Winniford M; Parkey RW; Buja LM; Willerson JT
Am J Cardiol; 1985 Aug; 56(4):252-6. PubMed ID: 4025161
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].
Hashimoto T; Kambara H; Nohara R; Fudo T; Uozu K; Tamaki S; Kawai C
J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242
[TBL] [Abstract][Full Text] [Related]
14. Myocsrdial uptake of technetium-99m stannous pyrophosphate following direct current transthoracic countershock.
DiCola VC; Freedman GS; Downing SE; Zaret BL
Circulation; 1976 Dec; 54(6):980-6. PubMed ID: 991415
[TBL] [Abstract][Full Text] [Related]
15. Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams.
Willerson JT; Parkey RW; Bonte FJ; Meyer SL; Stokely EM
Circulation; 1975 Mar; 51(3):436-41. PubMed ID: 166768
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m pyrophosphate tomogram of nontransmural myocardial infarction: a case report.
Kurata C; Sakata K; Taguchi T; Kobayashi A; Yamazaki N
Ann Nucl Med; 1988 Nov; 2(2):85-8. PubMed ID: 2856318
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs.
Buja LM; Parkey RW; Stokely EM; Bonte FJ; Willerson JT
J Clin Invest; 1976 Jun; 57(6):1508-22. PubMed ID: 180053
[TBL] [Abstract][Full Text] [Related]
18. Technetium pyrophosphate scanning in the detection of acute myocardial infarction: clinical experience.
Ko P; Kostuk WJ; Deatrich D
Can Med Assoc J; 1977 Feb; 116(3):260-3. PubMed ID: 189887
[TBL] [Abstract][Full Text] [Related]
19. Dual radionuclide study of myocardial infarction. Relationships between myocardial uptake of potassium-43, technetium-99m stannous pyrophosphate, regional myocardial blood flow and creatine phosphokinase depletion.
Zaret B; DiCola VC; Donabedian RK; Puri S; Wolfson S; Freedman GS; Cohen LS
Circulation; 1976 Mar; 53(3):422-8. PubMed ID: 174835
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of methods of myocardial scintigraphy using 99mTc-Sn-glucohepatonate and 99mTc-Sn-pyrophosphate in the diagnosis of acute myocardial infarction and unstable stenocardia].
Stepanova IP; Malyshev IuM
Kardiologiia; 1984 Mar; 24(3):31-5. PubMed ID: 6727090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
